Annual Press Conference 2011 - Boehringer Ingelheim

More documents

Recommendations

Info

125 years more health – The jubilee year 2010 Value through Innovation Annual Press Conference 2011 4
PRADAXA® for Stroke Prevention in Atrial Fibrillation Annual Press Conference 2011 • High unmet medical need and excellent growth potential • Rapid endorsement of PRADAXA® in leading international treatment guidelines • Cardiologists have quickly adopted and endorsed PRADAXA® • A lot of health insurances in the US and leading hospitals have placed PRADAXA® on the formulary 5
Page 1 and 2: Annual Press Conference 2011 Busine
Page 3: Highlights of the business year 201
Page 7 and 8: Our Businesses Net sales maintained
Page 9 and 10: Key Messages 2010 125 years more he
Page 11 and 12: Challenges of 2010 well managed Con
Page 13 and 14: Prescription Medicines Strong core
Page 15 and 16: Consumer Health Care Continued grow
Page 17 and 18: Top 10 Global Corporations 2010 in
Page 19 and 20: Animal Health Strong growth of 5 co
Page 21 and 22: Industrial Customer Business (ICB)
Page 23 and 24: Dynamic growth in emerging markets
Page 25 and 26: Operating Cash Flow covers investin
Page 27 and 28: The basis of longterm independence
Page 29 and 30: Outlook 2011 Andreas Barner Chairma
Page 31 and 32: Diabetes: Alliance with Eli Lilly a
Page 33 and 34: Biopharmaceuticals: Our Sites Cell
Page 35 and 36: Innovative power of our employees a
Page 37: Annual Press Conference 2011 Busine

Annual Press Conference 2011 - Boehringer Ingelheim

Create successful ePaper yourself

Delete template?

Save as template?